Hepatitis B vaccination in Indian children: Seroprotection and age-related change in antibody titres
Globally, childhood immunization against Hepatitis B is the most effective strategy in reducing the burden of chronic hepatitis B infection. In India, limited data is available on both anti-Hep B antibody titres in children after vaccination and age-related decline in the titres.
Know how this study helped estimate the proportion of children who developed protective levels of anti-hepatitis B antibodies after childhood vaccination and also examined changes in antibody titres with age in those children.
Childhood immunization against hepatitis B is one of the most effective strategies for reducing the global burden of chronic hepatitis B infection and its sequelae. There are limited data from India on both the anti-Hep B antibody titres in children after vaccination and the age-related decline in the titres. This study was planned to estimate the proportion of children in the age group of 1–10 years who develop protective levels of anti-hepatitis B antibodies after childhood vaccination and to examine the change in antibody titres with age in these children.
A hospital-based cross-sectional study was carried out in children admitted to the hospital for various ailments. Basic demographic data, vaccination history and HBsAg status of the mother were recorded. All the enrolled children were evaluated for HBsAg and anti-hepatitis B surface antibody (anti-HBS) titres. Institutional ethical clearance was obtained, and informed consent from the parents of the children was taken before drawing samples.
We found that 68.86% Confidence Interval ([CI]: 59.8–76.8%) of the children showed protective antibody titres after vaccination, while 31.14% (CI: 23.1–40.2%) of the children had titres less than 10 IU/L. Although 100% of children in the age group from birth to three years had titres more than 10 IU/L, this percentage showed a decline across the age groups, and 60% of children aged 9–10 years had titres less than 10 IU/L.
Childhood vaccination against hepatitis B is effective in 68% children, and the antibody levels showed a steady decline with increasing age.
For more details on the article
- Kumar D, Srivastava S, Tevatia MS, et al. Hepatitis B vaccination in Indian children: Seroprotection and age-related change in antibody titres. Medical Journal Armed Forces India.2021 Apr 1;77(2):200-4. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042511/
You May Also Like
Timeliness in the uptake of hepatitis B birth dose among Indian children under age five: A populationbased study
Global epidemiology and burden of tetanus from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
The proportion of unvaccinated children across 36 Indian states and union territories from 1993 to 2021
Immunogenicity of a liquid hexavalent DTaP-IPV-HB-PRP~T vaccine after primary and booster vaccination of term and preterm infants born to women vaccinated with Tdap during pregnancy
Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under- vaccinated children, a cross-sectional study in five Indian districts, 2018–20
Non-immunization associated with increased risk of sudden unexpected death in infancy: A national case-control study
The effect of the COVID-19 pandemic on routine childhood immunization coverage and timeliness in India: Retrospective analysis of the National Family Health Survey of 2019-2021 data
Vaccine Preventable Diseases in Pediatric Palliative Care: A Multicenter Cross-Sectional Study
Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: A before-and-after cross-sectional household serosurvey in four districts, 2018–2020